{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:46:29Z","timestamp":1780616789238,"version":"3.54.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["24-25-00210"],"award-info":[{"award-number":["24-25-00210"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s13346-025-01900-1","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T21:11:15Z","timestamp":1753909875000},"page":"162-179","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Development of 223Ra-labeled polymeric nanocarriers with variable administration routes for alpha-therapy of colorectal cancer"],"prefix":"10.1007","volume":"16","author":[{"given":"Alisa S.","family":"Postovalova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladislava A.","family":"Rusakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darya R.","family":"Akhmetova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia A.","family":"Tishchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry S.","family":"Sysoev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail A.","family":"Nadporojskii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin S.","family":"Sivak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei A.","family":"Shipilovskikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0276-7892","authenticated-orcid":false,"given":"Alexander S.","family":"Timin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"key":"1900_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"1900_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3322\/caac.21772","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73:233\u201354. https:\/\/doi.org\/10.3322\/caac.21772.","journal-title":"CA Cancer J Clin"},{"key":"1900_CR3","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.annonc.2023.12.003","volume":"35","author":"C Santucci","year":"2024","unstructured":"Santucci C, Mignozzi S, Malvezzi M, Boffetta P, Collatuzzo G, Levi F, La Vecchia C, Negri E. European cancer mortality predictions for the year 2024 with focus on colorectal cancer. Ann Oncol. 2024;35:308\u201316. https:\/\/doi.org\/10.1016\/j.annonc.2023.12.003.","journal-title":"Ann Oncol"},{"key":"1900_CR4","doi-asserted-by":"publisher","first-page":"101639","DOI":"10.1016\/j.jgo.2023.101639","volume":"15","author":"MR Moreno-Carmona","year":"2024","unstructured":"Moreno-Carmona MR, Serra-Prat M, Riera SA, Estrada O, Ferro T, Querol R. Effect of frailty on postoperative complications, mortality, and survival in older patients with non-metastatic colon cancer: A systematic review and meta-analysis. J Geriatr Oncol. 2024;15:101639. https:\/\/doi.org\/10.1016\/j.jgo.2023.101639.","journal-title":"J Geriatr Oncol"},{"key":"1900_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","volume":"34","author":"A Cervantes","year":"2023","unstructured":"Cervantes A, Adam R, Rosell\u00f3 S, Arnold D, Normanno N, Ta\u00efeb J, Seligmann J, De Baere T, Osterlund P, Yoshino T, Martinelli E. Metastatic colorectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34:10\u201332. https:\/\/doi.org\/10.1016\/j.annonc.2022.10.003.","journal-title":"Ann Oncol"},{"key":"1900_CR6","doi-asserted-by":"publisher","first-page":"062","DOI":"10.1055\/s-0043-1761420","volume":"37","author":"A Feria","year":"2024","unstructured":"Feria A, Times M. Effectiveness of standard treatment for stage 4 colorectal cancer: traditional management with surgery, radiation, and chemotherapy. Clin Colon Rectal Surg. 2024;37:062\u20135. https:\/\/doi.org\/10.1055\/s-0043-1761420.","journal-title":"Clin Colon Rectal Surg"},{"key":"1900_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/jso.27776","author":"N Tinsley","year":"2024","unstructured":"Tinsley N, O\u2019Dwyer ST, Nagaraju R, Chakrabarty B, Braun M, Mullamitha S, Kamposioras K, Marti Marti FE, Saunders M, Clouston H, Selvasekar C, Wild J, Wilson M, Renehan A, Aziz O, Barriuso J. Preoperative chemotherapy response and survival in patients with colorectal cancer peritoneal metastases. J Surg Oncol. 2024. https:\/\/doi.org\/10.1002\/jso.27776.","journal-title":"J Surg Oncol"},{"key":"1900_CR8","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1186\/s12885-018-4572-6","volume":"18","author":"Z Kozovska","year":"2018","unstructured":"Kozovska Z, Patsalias A, Bajzik V, Durinikova E, Demkova L, Jargasova S, Smolkova B, Plava J, Kucerova L, Matuskova M. ALDH1A Inhibition sensitizes colon cancer cells to chemotherapy. BMC Cancer. 2018;18:656. https:\/\/doi.org\/10.1186\/s12885-018-4572-6.","journal-title":"BMC Cancer"},{"key":"1900_CR9","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1093\/annonc\/mdu145","volume":"25","author":"KM Kerr","year":"2014","unstructured":"Kerr KM, Bubendorf L, Edelman MJ, Marchetti A, Mok T, Novello S, O\u2019Byrne K, Stahel R, Peters S, Felip E, Stahel R, Felip E, Peters S, Kerr K, Besse B, Vansteenkiste J, Eberhardt W, Edelman M, Mok T, O\u2019Byrne K, Novello S, Bubendorf L, Marchetti A, Baas P, Reck M, Syrigos K, Paz-Ares L, Smit EF, Meldgaard P, Adjei A, Nicolson M, Crin\u00f2 L, Van Schil P, Senan S, Faivre-Finn C, Rocco G, Veronesi G, Douillard J-Y, Lim E, Dooms C, Weder W, De Ruysscher D, Le Pechoux C, De Leyn P, Westeel V. Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer. Ann Oncol. 2014;25:1681\u201390. https:\/\/doi.org\/10.1093\/annonc\/mdu145.","journal-title":"Ann Oncol"},{"key":"1900_CR10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41392-023-01462-z","volume":"8","author":"S Guo","year":"2023","unstructured":"Guo S, Yao Y, Tang Y, Xin Z, Wu D, Ni C, Huang J, Wei Q, Zhang T. Radiation-induced tumor immune microenvironments and potential targets for combination therapy. Signal Transduct Target Ther. 2023;8:205. https:\/\/doi.org\/10.1038\/s41392-023-01462-z.","journal-title":"Signal Transduct Target Ther"},{"key":"1900_CR11","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1001\/jamaoncol.2018.4044","volume":"4","author":"C Parker","year":"2018","unstructured":"Parker C, Lewington V, Shore N, Kratochwil C, Levy M, Lind\u00e9n O, Noordzij W, Park J, Saad F. Targeted alpha therapy, an emerging class of Cancer agents. JAMA Oncol. 2018;4:1765. https:\/\/doi.org\/10.1001\/jamaoncol.2018.4044.","journal-title":"JAMA Oncol"},{"key":"1900_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3390\/pharmaceutics13010049","volume":"13","author":"BJB Nelson","year":"2020","unstructured":"Nelson BJB, Andersson JD, Wuest F. Targeted alpha therapy: progress in radionuclide production, radiochemistry, and applications. Pharmaceutics. 2020;13:49. https:\/\/doi.org\/10.3390\/pharmaceutics13010049.","journal-title":"Pharmaceutics"},{"key":"1900_CR13","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s13277-011-0286-y","volume":"33","author":"Y-S Kim","year":"2012","unstructured":"Kim Y-S, Brechbiel MW. An overview of targeted alpha therapy. Tumor Biology. 2012;33:573\u201390. https:\/\/doi.org\/10.1007\/s13277-011-0286-y.","journal-title":"Tumor Biology"},{"key":"1900_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2967\/jnmt.121.262294","volume":"50","author":"B Serencsits","year":"2022","unstructured":"Serencsits B, Chu BP, Pandit-Taskar N, McDevitt MR, Dauer LT. Radiation safety considerations and clinical advantages of \u03b1-Emitting therapy radionuclides. J Nucl Med Technol. 2022;50:10\u20136. https:\/\/doi.org\/10.2967\/jnmt.121.262294.","journal-title":"J Nucl Med Technol"},{"key":"1900_CR15","doi-asserted-by":"publisher","first-page":"12037","DOI":"10.1039\/D0CS00031K","volume":"50","author":"DM Griffith","year":"2021","unstructured":"Griffith DM, Li H, Werrett MV, Andrews PC, Sun H. Medicinal chemistry and biomedical applications of bismuth-based compounds and nanoparticles. Chem Soc Rev. 2021;50:12037\u201369. https:\/\/doi.org\/10.1039\/D0CS00031K.","journal-title":"Chem Soc Rev"},{"key":"1900_CR16","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.3390\/pharmaceutics14102024","volume":"14","author":"G Poletto","year":"2022","unstructured":"Poletto G, Evangelista L, Venturini F, Gramegna F, Seno F, Moro S, Vettor R, Realdon N, Cecchin D. Nanoparticles and radioisotopes: A long story in a nutshell. Pharmaceutics. 2022;14:2024. https:\/\/doi.org\/10.3390\/pharmaceutics14102024.","journal-title":"Pharmaceutics"},{"key":"1900_CR17","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3390\/ijms25010664","volume":"25","author":"G Trencs\u00e9nyi","year":"2024","unstructured":"Trencs\u00e9nyi G, Csikos C, K\u00e9pes Z. Targeted radium alpha therapy in the era of nanomedicine: in vivo results. Int J Mol Sci. 2024;25:664. https:\/\/doi.org\/10.3390\/ijms25010664.","journal-title":"Int J Mol Sci"},{"key":"1900_CR18","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.jconrel.2021.01.008","volume":"330","author":"AR Muslimov","year":"2021","unstructured":"Muslimov AR, Antuganov D, Tarakanchikova YV, Karpov TE, Zhukov MV, Zyuzin MV, Timin AS. An investigation of calcium carbonate core-shell particles for incorporation of 225Ac and sequester of daughter radionuclides: in vitro and in vivo studies. J Controlled Release. 2021;330:726\u201337. https:\/\/doi.org\/10.1016\/j.jconrel.2021.01.008.","journal-title":"J Controlled Release"},{"key":"1900_CR19","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/jlcr.3610","volume":"61","author":"S Westr\u00f8m","year":"2018","unstructured":"Westr\u00f8m S, Malenge M, Jorstad IS, Napoli E, Bruland \u00d8S, B\u00f8nsdorff TB, Larsen RH. Ra-224 labeling of calcium carbonate microparticles for internal \u03b1\u2010therapy: preparation, stability, and biodistribution in mice. J Label Comp Radiopharm. 2018;61:472\u201386. https:\/\/doi.org\/10.1002\/jlcr.3610.","journal-title":"J Label Comp Radiopharm"},{"key":"1900_CR20","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1524\/ract.2013.2066","volume":"101","author":"MF McLaughlin","year":"2013","unstructured":"McLaughlin MF, Woodward J, Boll RA, Rondinone AJ, Mirzadeh S, Robertson JD. Gold-coated lanthanide phosphate nanoparticles for an 225 ac in vivo alpha generator. Ract. 2013;101:595\u2013600. https:\/\/doi.org\/10.1524\/ract.2013.2066.","journal-title":"Ract"},{"key":"1900_CR21","doi-asserted-by":"publisher","unstructured":"Toro-Gonz\u00e1lez M, Dame AN, Mirzadeh S, Rojas JV. Gadolinium vanadate nanocrystals as carriers of \u03b1-emitters (225Ac, 227Th) and contrast agents. J Appl Phys. 2019;125. https:\/\/doi.org\/10.1063\/1.5096880.","DOI":"10.1063\/1.5096880"},{"key":"1900_CR22","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.3390\/molecules25051025","volume":"25","author":"E C\u0119drowska","year":"2020","unstructured":"C\u0119drowska E, Pruszy\u0144ski M, Gaw\u0119da W, \u017buk M, Krysi\u0144ski P, Bruchertseifer F, Morgenstern A, Karageorgou M-A, Bouziotis P, Bilewicz A. Trastuzumab conjugated superparamagnetic Iron oxide nanoparticles labeled with 225Ac as a perspective tool for combined \u03b1-Radioimmunotherapy and magnetic hyperthermia of HER2-Positive breast Cancer. Molecules. 2020;25:1025. https:\/\/doi.org\/10.3390\/molecules25051025.","journal-title":"Molecules"},{"key":"1900_CR23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11051-018-4181-y","volume":"20","author":"E C\u0119drowska","year":"2018","unstructured":"C\u0119drowska E, Pruszynski M, Majkowska-Pilip A, M\u0119czy\u0144ska-Wielgosz S, Bruchertseifer F, Morgenstern A, Bilewicz A. Functionalized TiO2 nanoparticles labelled with 225Ac for targeted alpha radionuclide therapy. J Nanopart Res. 2018;20:83. https:\/\/doi.org\/10.1007\/s11051-018-4181-y.","journal-title":"J Nanopart Res"},{"key":"1900_CR24","doi-asserted-by":"publisher","first-page":"897","DOI":"10.2967\/jnumed.115.158311","volume":"56","author":"ML Matson","year":"2015","unstructured":"Matson ML, Villa CH, Ananta JS, Law JJ, Scheinberg DA, Wilson LJ. Encapsulation of \u03b1-Particle\u2013Emitting 225 ac 3+ ions within carbon nanotubes. J Nucl Med. 2015;56:897\u2013900. https:\/\/doi.org\/10.2967\/jnumed.115.158311.","journal-title":"J Nucl Med"},{"key":"1900_CR25","doi-asserted-by":"publisher","unstructured":"Gr\u00f8nnings\u00e6ter SR, Blakkisrud J, Selboe S, Revheim M-E, Bruland \u00d8S, B\u00f8nsdorff TB, Larsen SG, Stokke C. Radiation safety considerations for the use of radium-224-calciumcarbonate-microparticles in patients with peritoneal metastasis. Front Med (Lausanne). 2023;10. https:\/\/doi.org\/10.3389\/fmed.2023.1058914.","DOI":"10.3389\/fmed.2023.1058914"},{"key":"1900_CR26","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2174\/1874471013666201201102056","volume":"14","author":"RG Li","year":"2021","unstructured":"Li RG, Napoli E, Jorstad IS, B\u00f8nsdorff TB, Juzeniene A, Bruland \u00d8S, Larsen RH, Westr\u00f8m S. Calcium carbonate microparticles as carriers of 224 ra: impact of specific activity in mice with intraperitoneal ovarian Cancer. Curr Radiopharm. 2021;14:145\u201353. https:\/\/doi.org\/10.2174\/1874471013666201201102056.","journal-title":"Curr Radiopharm"},{"key":"1900_CR27","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1039\/D3BM01651J","volume":"12","author":"DR Akhmetova","year":"2024","unstructured":"Akhmetova DR, Mitusova KA, Postovalova AS, Ivkina AS, Muslimov AR, Zyuzin MV, Shipilovskikh SA, Timin AS. Size-dependent therapeutic efficiency of 223 Ra-labeled calcium carbonate carriers for internal radionuclide therapy of breast cancer. Biomater Sci. 2024;12:453\u201367. https:\/\/doi.org\/10.1039\/D3BM01651J.","journal-title":"Biomater Sci"},{"key":"1900_CR28","doi-asserted-by":"publisher","first-page":"634","DOI":"10.3390\/pharmaceutics13050634","volume":"13","author":"RG Li","year":"2021","unstructured":"Li RG, Lindland K, Tonstad SK, B\u00f8nsdorff TB, Juzeniene A, Westr\u00f8m S, Larsen RH. Improved formulation of 224Ra-Labeled calcium carbonate microparticles by surface layer encapsulation and addition of EDTMP. Pharmaceutics. 2021;13:634. https:\/\/doi.org\/10.3390\/pharmaceutics13050634.","journal-title":"Pharmaceutics"},{"key":"1900_CR29","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.addr.2016.03.010","volume":"107","author":"E Castro-Aguirre","year":"2016","unstructured":"Castro-Aguirre E, I\u00f1iguez-Franco F, Samsudin H, Fang X, Auras R. Poly(lactic acid)\u2014Mass production, processing, industrial applications, and end of life. Adv Drug Deliv Rev. 2016;107:333\u201366. https:\/\/doi.org\/10.1016\/j.addr.2016.03.010.","journal-title":"Adv Drug Deliv Rev"},{"key":"1900_CR30","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ijpharm.2005.03.003","volume":"295","author":"MN Freitas","year":"2005","unstructured":"Freitas MN, Marchetti JM. Nimesulide PLA microspheres as a potential sustained release system for the treatment of inflammatory diseases. Int J Pharm. 2005;295:201\u201311. https:\/\/doi.org\/10.1016\/j.ijpharm.2005.03.003.","journal-title":"Int J Pharm"},{"key":"1900_CR31","doi-asserted-by":"publisher","first-page":"8846","DOI":"10.3390\/ijms21228846","volume":"21","author":"G Pepe","year":"2020","unstructured":"Pepe G, Calce E, Verdoliva V, Saviano M, Maglione V, Di Pardo A. De luca, Curcumin-Loaded nanoparticles based on amphiphilic Hyaluronan-Conjugate explored as targeting delivery system for neurodegenerative disorders. Int J Mol Sci. 2020;21:8846. https:\/\/doi.org\/10.3390\/ijms21228846.","journal-title":"Int J Mol Sci"},{"key":"1900_CR32","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.eurpolymj.2017.05.036","volume":"93","author":"S Medel","year":"2017","unstructured":"Medel S, Syrova Z, Kovacik L, Hrdy J, Hornacek M, Jager E, Hruby M, Lund R, Cmarko D, Stepanek P, Raska I, Nystr\u00f6m B. Curcumin-bortezomib loaded polymeric nanoparticles for synergistic cancer therapy. Eur Polym J. 2017;93:116\u201331. https:\/\/doi.org\/10.1016\/j.eurpolymj.2017.05.036.","journal-title":"Eur Polym J"},{"key":"1900_CR33","doi-asserted-by":"publisher","first-page":"35267","DOI":"10.1038\/srep35267","volume":"6","author":"Y Zhao","year":"2016","unstructured":"Zhao Y, Huan M, Liu M, Cheng Y, Sun Y, Cui H, Liu D, Mei Q, Zhou S. Doxorubicin and Resveratrol co-delivery nanoparticle to overcome doxorubicin resistance. Sci Rep. 2016;6:35267. https:\/\/doi.org\/10.1038\/srep35267.","journal-title":"Sci Rep"},{"key":"1900_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jconrel.2017.06.006","volume":"261","author":"V Shalgunov","year":"2017","unstructured":"Shalgunov V, Zaytseva-Zotova D, Zintchenko A, Levada T, Shilov Y, Andreyev D, Dzhumashev D, Metelkin E, Urusova A, Demin O, McDonnell K, Troiano G, Zale S, Safarov\u0430 E. Comprehensive study of the drug delivery properties of poly(l -lactide)-poly(ethylene glycol) nanoparticles in rats and tumor-bearing mice. J Controlled Release. 2017;261:31\u201342. https:\/\/doi.org\/10.1016\/j.jconrel.2017.06.006.","journal-title":"J Controlled Release"},{"key":"1900_CR35","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S0168-3659(02)00211-0","volume":"83","author":"M Chorny","year":"2002","unstructured":"Chorny M, Fishbein I, Danenberg HD, Golomb G. Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics. J Controlled Release. 2002;83:389\u2013400. https:\/\/doi.org\/10.1016\/S0168-3659(02)00211-0.","journal-title":"J Controlled Release"},{"key":"1900_CR36","doi-asserted-by":"publisher","first-page":"93995","DOI":"10.1039\/C5RA17729D","volume":"5","author":"P Mukhopadhyay","year":"2015","unstructured":"Mukhopadhyay P, Kundu PP. Chitosan-graft-PAMAM\u2013alginate core\u2013shell nanoparticles: a safe and promising oral insulin carrier in an animal model. RSC Adv. 2015;5:93995\u20134007. https:\/\/doi.org\/10.1039\/C5RA17729D.","journal-title":"RSC Adv"},{"key":"1900_CR37","doi-asserted-by":"publisher","first-page":"16014","DOI":"10.1038\/natrevmats.2016.14","volume":"1","author":"S Wilhelm","year":"2016","unstructured":"Wilhelm S, Tavares AJ, Dai Q, Ohta S, Audet J, Dvorak HF, Chan WCW. Analysis of nanoparticle delivery to tumours. Nat Rev Mater. 2016;1:16014. https:\/\/doi.org\/10.1038\/natrevmats.2016.14.","journal-title":"Nat Rev Mater"},{"key":"1900_CR38","doi-asserted-by":"crossref","unstructured":"Hasani Bijarbooneh F, Zhao Y, Kim JH, Sun Z, Malgras V, Aboutalebi SH, Heo Y, Ikegami M, Dou SX. aqueous colloidal stability evaluated by zeta potential measurement and resultant\u2009<\u2009scp\u2009>\u2009<\u2009scp\u20092 for superior photovoltaic performance, Journal of the American Ceramic Society 96 (2013) 2636\u20132643. https:\/\/doi.org\/10.1111\/jace.12371","DOI":"10.1111\/jace.12371"},{"key":"1900_CR39","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3109\/08982100903311812","volume":"20","author":"A Helbok","year":"2010","unstructured":"Helbok A, Decristoforo C, Dobrozemsky G, Rangger C, Diederen E, Stark B, Prassl R, von Guggenberg E. Radiolabeling of lipid-based nanoparticles for diagnostics and therapeutic applications: a comparison using different radiometals. J Liposome Res. 2010;20:219\u201327. https:\/\/doi.org\/10.3109\/08982100903311812.","journal-title":"J Liposome Res"},{"key":"1900_CR40","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3390\/ph7040392","volume":"7","author":"K Stockhofe","year":"2014","unstructured":"Stockhofe K, Postema J, Schieferstein H, Ross T. Radiolabeling of nanoparticles and polymers for PET imaging. Pharmaceuticals. 2014;7:392\u2013418. https:\/\/doi.org\/10.3390\/ph7040392.","journal-title":"Pharmaceuticals"},{"key":"1900_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2022.02.021","volume":"344","author":"AS Timin","year":"2022","unstructured":"Timin AS, Postovalova AS, Karpov TE, Antuganov D, Bukreeva AS, Akhmetova DR, Rogova AS, Muslimov AR, Rodimova SA, Kuznetsova DS, Zyuzin MV. Calcium carbonate carriers for combined chemo- and radionuclide therapy of metastatic lung cancer. J Controlled Release. 2022;344:1\u201311. https:\/\/doi.org\/10.1016\/j.jconrel.2022.02.021.","journal-title":"J Controlled Release"},{"key":"1900_CR42","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s11051-016-3482-2","volume":"18","author":"SE Favela-Camacho","year":"2016","unstructured":"Favela-Camacho SE, P\u00e9rez-Robles JF, Garc\u00eda-Casillas PE, Godinez-Garcia A. Stability of magnetite nanoparticles with different coatings in a simulated blood plasma. J Nanopart Res. 2016;18:176. https:\/\/doi.org\/10.1007\/s11051-016-3482-2.","journal-title":"J Nanopart Res"},{"key":"1900_CR43","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12951-021-00963-9","volume":"19","author":"H Kato","year":"2021","unstructured":"Kato H, Huang X, Kadonaga Y, Katayama D, Ooe K, Shimoyama A, Kabayama K, Toyoshima A, Shinohara A, Hatazawa J, Fukase K. Intratumoral administration of astatine-211-labeled gold nanoparticle for alpha therapy. J Nanobiotechnol. 2021;19:223. https:\/\/doi.org\/10.1186\/s12951-021-00963-9.","journal-title":"J Nanobiotechnol"},{"key":"1900_CR44","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/s41551-022-00949-4","volume":"6","author":"JL Schaal","year":"2022","unstructured":"Schaal JL, Bhattacharyya J, Brownstein J, Strickland KC, Kelly G, Saha S, Milligan J, Banskota S, Li X, Liu W, Kirsch DG, Zalutsky MR, Chilkoti A. Brachytherapy via a depot of biopolymer-bound 131I synergizes with nanoparticle Paclitaxel in therapy-resistant pancreatic tumours. Nat Biomed Eng. 2022;6:1148\u201366. https:\/\/doi.org\/10.1038\/s41551-022-00949-4.","journal-title":"Nat Biomed Eng"},{"key":"1900_CR45","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1007\/s00259-024-06612-1","volume":"51","author":"S Ghosh","year":"2024","unstructured":"Ghosh S, Patra S, Younis MH, Chakraborty A, Guleria A, Gupta SK, Singh K, Rakhshit S, Chakraborty S, Cai W, Chakravarty R. Brachytherapy at the nanoscale with protein functionalized and intrinsically radiolabeled [169Yb]Yb2O3 nanoseeds. Eur J Nucl Med Mol Imaging. 2024;51:1558\u201373. https:\/\/doi.org\/10.1007\/s00259-024-06612-1.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1900_CR46","doi-asserted-by":"publisher","first-page":"102753","DOI":"10.1016\/j.nano.2024.102753","volume":"59","author":"AS Postovalova","year":"2024","unstructured":"Postovalova AS, Tishchenko YA, Istomina MS, Karpov TE, Shipilovskikh SA, Akhmetova D, Rogova A, Gavrilova NV, Timin AS. Comparison of passive targeted delivery of inorganic and organic nanocarriers among different types of tumors. Nanomedicine. 2024;59:102753. https:\/\/doi.org\/10.1016\/j.nano.2024.102753.","journal-title":"Nanomedicine"},{"key":"1900_CR47","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jconrel.2023.06.012","volume":"359","author":"AA Yakubova","year":"2023","unstructured":"Yakubova AA, Mitusova KA, Darwish A, Rogova A, Ageev EI, Brodskaia A, Muslimov AR, Zyuzin MV, Timin AS. Calcium carbonate nanoparticles tumor delivery for combined chemo-photodynamic therapy: comparison of local and systemic administration. J Controlled Release. 2023;359:400\u201314. https:\/\/doi.org\/10.1016\/j.jconrel.2023.06.012.","journal-title":"J Controlled Release"},{"key":"1900_CR48","doi-asserted-by":"publisher","first-page":"6593","DOI":"10.1021\/acs.chemmater.2c01507","volume":"34","author":"T Karpov","year":"2022","unstructured":"Karpov T, Postovalova A, Akhmetova D, Muslimov AR, Eletskaya E, Zyuzin MV, Timin AS. Universal Chelator-Free radiolabeling of organic and Inorganic-Based nanocarriers with diagnostic and therapeutic isotopes for internal radiotherapy. Chem Mater. 2022;34:6593\u2013605. https:\/\/doi.org\/10.1021\/acs.chemmater.2c01507.","journal-title":"Chem Mater"},{"key":"1900_CR49","doi-asserted-by":"publisher","unstructured":"Colino CI, Lanao JM, Gutierrez-Millan C. Targeting of hepatic macrophages by therapeutic nanoparticles. Front Immunol. 2020;11. https:\/\/doi.org\/10.3389\/fimmu.2020.00218.","DOI":"10.3389\/fimmu.2020.00218"},{"key":"1900_CR50","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1016\/j.apsb.2021.03.033","volume":"11","author":"M Zhang","year":"2021","unstructured":"Zhang M, Gao S, Yang D, Fang Y, Lin X, Jin X, Liu Y, Liu X, Su K, Shi K. Influencing factors and strategies of enhancing nanoparticles into tumors in vivo. Acta Pharm Sin B. 2021;11:2265\u201385. https:\/\/doi.org\/10.1016\/j.apsb.2021.03.033.","journal-title":"Acta Pharm Sin B"},{"key":"1900_CR51","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41578-018-0038-3","volume":"3","author":"B Du","year":"2018","unstructured":"Du B, Yu M, Zheng J. Transport and interactions of nanoparticles in the kidneys. Nat Rev Mater. 2018;3:358\u201374. https:\/\/doi.org\/10.1038\/s41578-018-0038-3.","journal-title":"Nat Rev Mater"},{"key":"1900_CR52","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1021\/acsnano.5b05066","volume":"10","author":"X Liang","year":"2016","unstructured":"Liang X, Wang H, Zhu Y, Zhang R, Cogger VC, Liu X, Xu ZP, Grice JE, Roberts MS. Short- and Long-Term tracking of anionic ultrasmall nanoparticles in kidney. ACS Nano. 2016;10:387\u201395. https:\/\/doi.org\/10.1021\/acsnano.5b05066.","journal-title":"ACS Nano"},{"key":"1900_CR53","doi-asserted-by":"publisher","unstructured":"Pouget J-P, Constanzo J. Revisiting the radiobiology of targeted alpha therapy. Front Med (Lausanne). 2021;8. https:\/\/doi.org\/10.3389\/fmed.2021.692436.","DOI":"10.3389\/fmed.2021.692436"},{"key":"1900_CR54","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.3390\/cells10061539","volume":"10","author":"VS e Silva","year":"2021","unstructured":"e Silva VS, Abdallah EA, de Flores B, Braun AC, de Costa D, Ruano APC, Gasparini VA, Silva MLG, Mendes GG, Claro LCL, Calsavara VF, Aguiar Junior S, de Mello CAL. Chinen, molecular and dynamic evaluation of proteins related to resistance to neoadjuvant treatment with chemoradiotherapy in Circulating tumor cells of patients with locally advanced rectal Cancer. Cells. 2021;10:1539. https:\/\/doi.org\/10.3390\/cells10061539.","journal-title":"Cells"},{"key":"1900_CR55","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.3748\/wjg.v24.i34.3834","volume":"24","author":"K Van der Jeught","year":"2018","unstructured":"Van der Jeught K, Xu H-C, Li Y-J, Lu X-B, Ji G. Drug resistance and new therapies in colorectal cancer. World J Gastroenterol. 2018;24:3834\u201348. https:\/\/doi.org\/10.3748\/wjg.v24.i34.3834.","journal-title":"World J Gastroenterol"},{"key":"1900_CR56","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"S Elmore","year":"2007","unstructured":"Elmore S. Apoptosis: A review of programmed cell death. Toxicol Pathol. 2007;35:495\u2013516. https:\/\/doi.org\/10.1080\/01926230701320337.","journal-title":"Toxicol Pathol"},{"key":"1900_CR57","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/17425247.2021.1874916","volume":"19","author":"R Islam","year":"2022","unstructured":"Islam R, Maeda H, Fang J. Factors affecting the dynamics and heterogeneity of the EPR effect: pathophysiological and Pathoanatomic features, drug formulations and physicochemical factors. Expert Opin Drug Deliv. 2022;19:199\u2013212. https:\/\/doi.org\/10.1080\/17425247.2021.1874916.","journal-title":"Expert Opin Drug Deliv"},{"key":"1900_CR58","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","volume":"65","author":"H Maeda","year":"2000","unstructured":"Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Controlled Release. 2000;65:271\u201384. https:\/\/doi.org\/10.1016\/S0168-3659(99)00248-5.","journal-title":"J Controlled Release"},{"key":"1900_CR59","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/978-3-319-98947-1_5","volume-title":"Radiopharmaceutical chemistry","author":"M Grzmil","year":"2019","unstructured":"Grzmil M, Meisel A, Beh\u00e9 M, Schibli R. An overview of targeted radiotherapy. Radiopharmaceutical chemistry. Cham: Springer International Publishing; 2019. pp. 85\u2013100. https:\/\/doi.org\/10.1007\/978-3-319-98947-1_5."},{"key":"1900_CR60","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.tranon.2017.12.011","volume":"11","author":"S Westr\u00f8m","year":"2018","unstructured":"Westr\u00f8m S, B\u00f8nsdorff TB, Bruland \u00d8S, Larsen RH. Therapeutic effect of \u03b1-Emitting 224Ra-Labeled calcium carbonate microparticles in mice with intraperitoneal ovarian Cancer. Transl Oncol. 2018;11:259\u201367. https:\/\/doi.org\/10.1016\/j.tranon.2017.12.011.","journal-title":"Transl Oncol"},{"key":"1900_CR61","doi-asserted-by":"publisher","first-page":"117517","DOI":"10.1016\/j.bmc.2023.117517","volume":"96","author":"X Chen","year":"2023","unstructured":"Chen X, Liang R, Liu W, Ma H, Bai C, Xiong Y, Lan T, Liao J, Yang Y, Yang J, Li F, Liu N. Biocompatible conjugated polymer nanoparticles labeled with 225Ac for tumor endoradiotherapy. Bioorg Med Chem. 2023;96:117517. https:\/\/doi.org\/10.1016\/j.bmc.2023.117517.","journal-title":"Bioorg Med Chem"},{"key":"1900_CR62","doi-asserted-by":"publisher","first-page":"6831","DOI":"10.1021\/acsanm.3c05525","volume":"7","author":"F Li","year":"2024","unstructured":"Li F, Ma H, Luo H, Shen G, Su J, Cai H, Chen X, Lan T, Yang Y, Liao J. Liu, 211 At-Labeled nanoscale polydopamine decorated with FAPI for synergistic Targeted-Alpha therapy and photothermal therapy of glioma. ACS Appl Nano Mater. 2024;7:6831\u20138. https:\/\/doi.org\/10.1021\/acsanm.3c05525.","journal-title":"ACS Appl Nano Mater"},{"key":"1900_CR63","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.3390\/biomedicines11082169","volume":"11","author":"SK Marshall","year":"2023","unstructured":"Marshall SK, Kaewpradit N, Mudmarn T, Buathong J, Sriwirote P. Evaluation of single dose and fractionated dose of I-131 radiolabeled nanoparticles for Triple-Negative breast Cancer treatment. Biomedicines. 2023;11:2169. https:\/\/doi.org\/10.3390\/biomedicines11082169.","journal-title":"Biomedicines"},{"key":"1900_CR64","doi-asserted-by":"publisher","first-page":"14679","DOI":"10.1021\/jacs.3c02325","volume":"145","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Li F, Cui Z, Li K, Guan J, Tian L, Wang Y, Liu N, Wu W, Chai Z, Wang S. A radioluminescent Metal\u2013Organic framework for monitoring 225 ac in vivo. J Am Chem Soc. 2023;145:14679\u201385. https:\/\/doi.org\/10.1021\/jacs.3c02325.","journal-title":"J Am Chem Soc"},{"key":"1900_CR65","doi-asserted-by":"publisher","first-page":"11805","DOI":"10.2147\/IJN.S484976","volume":"19","author":"M Zhu","year":"2024","unstructured":"Zhu M, Zhao L, Lu X. Direct labeling of gold nanoparticles with Iodine-131 for tumor radionuclide therapy. Int J Nanomed Volume. 2024;19:11805\u201318. https:\/\/doi.org\/10.2147\/IJN.S484976.","journal-title":"Int J Nanomed Volume"},{"key":"1900_CR66","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.3390\/pharmaceutics14122705","volume":"14","author":"X Huang","year":"2022","unstructured":"Huang X, Kaneda-Nakashima K, Kadonaga Y, Kabayama K, Shimoyama A, Ooe K, Kato H, Toyoshima A, Shinohara A, Haba H, Wang Y, Fukase K. Astatine-211-Labeled gold nanoparticles for targeted Alpha-Particle therapy via intravenous injection. Pharmaceutics. 2022;14:2705. https:\/\/doi.org\/10.3390\/pharmaceutics14122705.","journal-title":"Pharmaceutics"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01900-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-025-01900-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01900-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T21:50:00Z","timestamp":1765144200000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-025-01900-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1900"],"URL":"https:\/\/doi.org\/10.1007\/s13346-025-01900-1","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,30]]},"assertion":[{"value":"10 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were performed in accordance with the Guidelines for Care and Use of Laboratory Animals of Smorodintsev Research Institute of Influenza (Ministry of Healthcare of the Russian Federation) and approved by the local Animal Ethics Committee of Smorodintsev Research Institute of Influenza (Ministry of Healthcare of the Russian Federation). Ethical approval order No. 60 dated 09.20.2022.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to be accountable for all aspects of the work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}